Joshua B. Cohen, Co-Chief Executive Officer at Amylyx Pharmaceuticals, Inc. (AMLX), sold 8,270 shares at $18.73 ($155K) on 2024-03-05, disclosed to the SEC on 2024-03-07.
Open-market sale of $155k AMLX by Co-Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.73 | 4,135 | $77K | 50.0% |
| 2 | $18.73 | 4,135 | $77K | 50.0% |
| Total | $18.73 avg | 8,270 | $155K | 100% |
| Filing → |
| AMLX | SELL | 2026-02-04 | $228K | — | Filing → |
| AMLX | SELL | 2026-01-20 | $1.9M | — | Filing → |
| AMLX | SELL | 2026-01-08 | $86K | — | Filing → |